FDA•MODERATE
Fluocinonide Cream 0.05%
Taro recalls Fluocinonide Cream 0.05% 15g tubes due to failed viscosity specs.
3 productsFilters
Category
Agency
Severity
Date
Distributed in
Drugs Recalls
Back to home ←
FDA•MODERATEFarmHouse Fresh Midnight Clearing Night LotionFarmHouse Fresh Night Lotion recalled due to benzene contamination.
4 products
FDA•MODERATECinacalcet Hydrochloride TabletsCipla recalls Cinacalcet HCl tablets over CGMP deviations and nitrosamine impurity.
3 products
FDA•MODERATEMenthol Cough Drops Honey LemonMGC Health recalls Honey Lemon cough drops over quality concerns from FDA inspection.
15 products
FDA•MODERATELanreotide Injection 120 mg/0.5 mLCipla recalls Lanreotide Injection 120 mg/0.5 mL over sterility assurance concerns.
2 products
FDA•MODERATEOmnipaque (iohexol) Injection 350 mg/mLGE Healthcare recalls Omnipaque 350 mg/mL injection due to particulate matter.
2 products
FDA•CRITICALBlaine Labs: multiple drugsBlaine Labs recalls Revitaderm Wound Care Gel and other products over microbial contamination.
9 products
FDA•CRITICALMagnesium Sulfate in Water for Injection IV BagAmneal is recalling Magnesium Sulfate IV bags (NDC 70121-1720-3) due to product mix-up with Tranexamic Acid.
FDA•MODERATEXanax XR Alprazolam 3 mg TabletsViatris is recalling Xanax XR 3 mg tablets (NDC 58151-506-91) due to failed dissolution specifications.
FDA•MODERATEVancomycin HCl InjectionFagron recalls Vancomycin HCl 1.5g/250mL injection over sterility concerns; port part may detach.
5 products
FDA•MODERATEGeri-Care Artificial Tears Lubricant Eye DropsGeri-Care Artificial Tears Lubricant Eye Drops (0.5 oz, NDC 68788-7266-0) recalled due to lack of sterility assurance.
FDA•MODERATEFresenius Kabi: Multiple Unit Of Sale Ndc Number ProductsFresenius Kabi recalls 14 lots of IV saline and dextrose solutions over sterility concerns.
14 products
FDA•MODERATEMeclizine Hydrochloride Tablets 12.5 mgAmerican Health Packaging is recalling Meclizine Hydrochloride 12.5 mg tablets (NDC 60687-775-65 and 60687-775-11) due to failed tablet specifications.
FDA•MODERATEPrazosin Hydrochloride Capsules 1mgAppco Pharma recalls Prazosin HCl 1mg capsules over nitrosamine impurity above acceptable limits.
3 products
FDA•MODERATEK.C. Pharmaceuticals: Multiple Eye Drops ProductsK.C. Pharmaceuticals recalls multiple brands of sterile eye drops due to lack of sterility assurance.
15 products
FDA•MODERATETramadol Hydrochloride Tablets 50 mgAmneal is recalling 500-count bottles of Tramadol Hydrochloride 50 mg tablets due to an impurity found during stability testing.
FDA•MODERATECurosurf (poractant alfa) 240 mg Intratracheal SuspensionChiesi USA is recalling Curosurf 240 mg intratracheal suspension vials (NDC 10122-510-03) due to lack of sterility assurance.
FDA•MODERATEOctreotide Acetate Injectable Suspension 20 mgTeva recalls Octreotide Acetate 20 mg vials over sterility concerns from FDA inspection findings.
6 products
FDA•MODERATEBrimonidine Tartrate/Timolol Maleate Ophthalmic SolutionApotex is recalling Brimonidine Tartrate/Timolol Maleate eye drops (NDC 60505-0589-1) due to lack of sterility assurance.
FDA•MODERATELevothyroxine Sodium Tablets USP 150 mcgMacleods Pharma recalls Levothyroxine Sodium 150 mcg tablets (NDC 33342-401-44) nationwide due to subpotency.
FDA•LOWSodium Iodide I-131 Kit Gelatin Capsule PackRadnostix is recalling Sodium Iodide I-131 Kit capsule packs due to failed product specifications.
FDA•MODERATEDexamethasone Sodium Phosphate Injection, USP 100 mg/10 mLSomerset Therapeutics is recalling Dexamethasone Sodium Phosphate Injection (NDC 70069-025-10/01) due to out-of-specification impurities at expiry.
FDA•MODERATEIcosapent Ethyl CapsulesZydus Pharmaceuticals is recalling Icosapent Ethyl Capsules due to oxidation, which can cause capsule melting and discoloration.
FDA•CRITICALWebcol Alcohol Prep Pads (70% Isopropyl Alcohol)Cardinal Health is recalling Webcol Alcohol Prep Pads (200-count boxes) due to microbial contamination that may pose infection risk.
3 products
FDA•MODERATEChildren's Ibuprofen Oral Suspension 100 mg/5mLTaro Pharmaceuticals is recalling Children's Ibuprofen Oral Suspension 100 mg/5mL (120 mL) due to gel-like masses and black particles.
FDA•CRITICALBlue Bull Extreme Male Enhancement SupplementBlue Bull Extreme Male Enhancement pouches recalled due to undeclared sildenafil.
3 products
FDA•MODERATETemozolomide Capsules 5mgRising Pharmaceuticals is recalling Temozolomide Capsules 5mg (NDC 16571-816-51) due to failed impurities and degradation specifications.
FDA•MODERATEAmnesteem Isotretinoin Capsules 40 mgMylan is recalling Amnesteem Isotretinoin 40 mg capsules (NDC 0378-6614-93) due to failed dissolution specifications.
FDA•MODERATESodium Iodide (I-131) Therapeutic Oral SolutionRadnostix is recalling Sodium Iodide (I-131) Therapeutic Oral Solution due to the presence of particulate matter.
FDA•MODERATEHTO Nevada: Multiple Dermal Source ProductsKirkman recalls lidocaine cream and spray due to unsupported expiry dates.
3 products
FDA•LOWCipla: Multiple Packaged In Cartons CapsulesCipla recalls Nilotinib Capsules (150 mg, 200 mg) over failed stability tests for appearance.
2 products
FDA•MODERATEMidodrine Hydrochloride Tablets, USP 5 mgMajor Pharmaceuticals is recalling Midodrine Hydrochloride Tablets 5 mg (NDC 0904-6818-06) due to inadequately sealed blister packaging.
FDA•MODERATEACME UNITED: multiple drugsAcme United is recalling 22 varieties of BZK Antiseptic Towelettes due to manufacturing process deviations.
22 products
FDA•MODERATESemaglutide (for Rx compounding use)Harbin Jixianglong recalls semaglutide API over CGMP deviations including missing process and endotoxin validation.
2 products
FDA•MODERATETeva Pharmaceuticals: multiple tabletsTeva recalls Metoprolol Succinate ER tablets (25-200 mg) over failed dissolution specs.
4 products
FDA•LOWEptifibatide Injection 75 mg/100 mLSlate Run Pharmaceuticals recalls Eptifibatide Injection 75 mg/100 mL vials (NDC 70436-027-80, 70436-163-80) due to incorrect dosing-route labeling.
FDA•MODERATEAmantadine HCl Capsules 100 mgAvKARE is recalling Amantadine HCl Capsules 100 mg (NDC 50268-069-15) nationwide due to failed dissolution specifications.
FDA•MODERATEAdbry (tralokinumab-ldrm) InjectionLEO Pharma is recalling Adbry (tralokinumab-ldrm) injection due to a lack of sterility assurance following the discovery of wool fiber.
FDA•CRITICALUdenyca Pegfilgrastim-cbqv InjectionAccord BioPharma is recalling Udenyca injection due to improper storage temperature conditions.
FDA•MODERATEOxycodone Hydrochloride 5 mg TabletsAmerican Health Packaging is recalling Oxycodone 5 mg tablets due to defective blister card seals that may cause tablets to fall out.
FDA•MODERATECetrorelix Acetate Injection KitMeitheal Pharmaceuticals is recalling Cetrorelix Acetate injection kits due to missing or duplicated needles in the delivery system.
FDA•MODERATEThiamine HCl Injection 500 mg/100 mLFresenius Kabi recalls thiamine HCl 500 mg/100 mL injection over sterility concerns.
5 products
FDA•MODERATETestosterone 100 mg Sterile PelletsAsteria Health recalls Testosterone 100 mg Sterile Pellets over possible metal contamination.
25 products
FDA•MODERATEDiclofenac Sodium Topical Gel 3%Taro Pharmaceuticals is recalling Diclofenac Sodium Topical Gel 3% (100 g) due to viscosity specification failure.
FDA•LOWDoxazosin Tablets, USP 4 mgUnichem is recalling Doxazosin Tablets 4 mg (NDC 29300-353-10) due to incorrect tablet imprinting that may cause medication errors.
FDA•MODERATETrazodone Hydrochloride 50 mg TabletsGranules Pharmaceuticals is recalling Trazodone Hydrochloride 50 mg tablets (NDC 70010-231-01) due to foreign tablets or capsules in bottles.
FDA•MODERATEPro Numb Tattoo Numbing SprayPro Numb Tattoo Numbing Spray recalled over cGMP deviations.
2 products
FDA•MODERATEBisoprolol Fumarate and Hydrochlorothiazide Tablets 2.5 mg/6.25 mgUnichem Pharmaceuticals recalls Bisoprolol/Hydrochlorothiazide 2.5/6.25 mg tablets (NDC 29300-187-01) due to N-Nitroso Bisoprolol impurity specification failure.
FDA•MODERATEMethylprednisolone Tablets USP Dosepak 4 mgGreenstone is recalling methylprednisolone 4 mg tablets (NDC 59762-4440-2) due to incorrect blister foil orientation causing incorrect dosing information.
FDA•MODERATEFurosemide Tablets USP 40 mgRising Pharmaceuticals is recalling Furosemide Tablets 40 mg (NDC 64980-563-10) due to foreign substance contamination.